Publications by authors named "Rachel Syme"

Claim this Profile
T
The Canadian Path from Discovery to Implementation of Personalized Medicine Approaches.
Étienne Richer, Rachel Syme, Stephen M Robbins, Paul Lasko

Biomed Hub· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Personalized Medicine in the Canadian Environment: Efforts Facilitating Oncology Clinical Research.
Rachel Syme, Bruce Carleton, Lada Leyens, Etienne Richer

Public Health Genomics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?
Britney Jones, Rachel Syme, Misha Eliasziw, Bernhard J Eigl

Can Urol Assoc J· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting nursing research and innovation by staff nurses.
Rachel Syme, Carla Stiles

Appl Nurs Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.
Hyo Sook Han, Isildinha M Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Rachel Syme

Eur J Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug cost avoidance resulting from cancer clinical trials.
Correne Bredin, Misha Eliasziw, Rachel Syme

Contemp Clin Trials· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of CD34 and monocyte-derived dendritic cells from mobilized peripheral blood from cancer patients.
Rachel Syme, Rubinder Bajwa, Laurie Robertson, Doug Stewart, Stefan Glück

Stem Cells· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients.
Shahbal B Kangarloo, Suman B Gangopadhyay, Rachel M Syme, Johannes E A Wolff, Stefan Glück

Med Oncol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming with dendritic cells can generate strong cytotoxic T cell responses to chronic myelogenous leukemia cells in vitro.
Rachel Syme, Tracey Bryan, Peter Duggan, Rubinder Bajwa, Doug Stewart

Stem Cells Dev· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes.
Rachel M Syme, Jason C L Spurrell, Ernest K Amankwah, Francis H Y Green, Christopher H Mody

Infect Immun· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis